BioStock: Aqilion – Disrupting the Vicious Cycle of Chronic Inflammation

Chronic inflammation is an underlying cause of many diseases and represents an immense societal burden. Researchers continue to struggle to solve the riddle behind this mechanism, and still treatments are lacking. Confronting the issue is the Swedish biotech Aqilion. BioStock spoke with the company's CEO Sarah Fredriksson to learn more about Aqilion’s vision and mission.

Read the interview with Aqilion's CEO Sarah Fredriksson at biostock.se:

Aqilion – Disrupting the Vicious Cycle of Chronic Inflammation - BioStock

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/